Last update 28 Jul 2025

Filgrastim-AAFI(Hospira, Inc.)

Overview

Basic Info

Drug Type
Biosimilar, Colony-stimulating factors
Synonyms
filgrastim, Filgrastim Biosimilar (Hospira, Inc.), FILGRASTIM-AAFI
+ [6]
Target
Action
agonists
Mechanism
CSF-3R agonists(Colony stimulating factor 3 receptor agonists)
Inactive Indication-
Originator Organization
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
European Union (07 Jun 2010),
Regulation-
Login to view timeline

Structure/Sequence

External Link

KEGGWikiATCDrug Bank
--

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Stem cell mobilisation
Australia
08 Sep 2011
Febrile Neutropenia
European Union
07 Jun 2010
Febrile Neutropenia
Iceland
07 Jun 2010
Febrile Neutropenia
Liechtenstein
07 Jun 2010
Febrile Neutropenia
Norway
07 Jun 2010
Neutropenia
European Union
07 Jun 2010
Neutropenia
Iceland
07 Jun 2010
Neutropenia
Liechtenstein
07 Jun 2010
Neutropenia
Norway
07 Jun 2010
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
541
bnreuuehqs(nakqvgvghc) = hddmvnykrb yvzxxqjlgb (dstwwkumce )
Positive
01 Feb 2024
bnreuuehqs(nakqvgvghc) = mrgkiavazd yvzxxqjlgb (dstwwkumce )
Not Applicable
541
fhdsygmoxe(ngatwilxfk) = guwcbapdgu yyosbbqtlk (iynywyupot )
-
10 Dec 2023
fhdsygmoxe(ngatwilxfk) = ugrqqdpyin yyosbbqtlk (iynywyupot )
Phase 1/2
92
(A - Tacrolimus, Methotrexate, Sirolimus (TMS) Arm)
yeorfdkone = vpbbcoyvel zdmwkczuwx (zkupnnutes, oppctxnjgj - jkjsautppy)
-
24 Aug 2017
yeorfdkone = geobcnrcxx zdmwkczuwx (zkupnnutes, aweixruhco - usuvhxxuyf)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free